{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:26:52Z","timestamp":1789759612435,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00277-020-04089-0","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T07:02:46Z","timestamp":1591772566000},"page":"1655-1665","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1007","volume":"99","author":[{"given":"Satoshi","family":"Kaito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Konuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Kishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Yoshifuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Inamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Toya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuho","family":"Najima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideharu","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Kakihana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuteru","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Sakamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8661-3179","authenticated-orcid":false,"given":"Noriko","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,10]]},"reference":[{"key":"4089_CR1","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.bbmt.2010.04.004","volume":"16","author":"SZ Pavletic","year":"2010","unstructured":"Pavletic SZ, Kumar S, Mohty M, de Lima M, Foran JM, Pasquini M, Zhang MJ, Giralt S, Bishop MR, Weisdorf D (2010) NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the epidemiology and natural history of relapse following allogeneic cell transplantation. Biol Blood Marrow Transplant 16:871\u2013890","journal-title":"Biol Blood Marrow Transplant"},{"key":"4089_CR2","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.bbmt.2010.08.001","volume":"16","author":"DL Porter","year":"2010","unstructured":"Porter DL, Alyea EP, Antin JH, DeLima M, Estey E, Falkenburg JH et al (2010) NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on treatment of relapse after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 16:1467\u20131503","journal-title":"Biol Blood Marrow Transplant"},{"key":"4089_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bbmt.2008.10.012","volume":"15","author":"ED Warlick","year":"2009","unstructured":"Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D (2009) Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Biol Blood Marrow Transplant 15:30\u201338","journal-title":"Biol Blood Marrow Transplant"},{"key":"4089_CR4","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.bbmt.2009.07.008","volume":"15","author":"PM Armistead","year":"2009","unstructured":"Armistead PM, de Lima M, Pierce S, Qiao W, Wang X, Thall PF, Giralt S, Ravandi F, Kantarjian H, Champlin R, Estey E (2009) Quantifying the survival benefit for allogeneic hematopoietic stem cell transplantation in relapsed acute myelogenous leukemia. Biol Blood Marrow Transplant 15:1431\u20131438","journal-title":"Biol Blood Marrow Transplant"},{"key":"4089_CR5","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.bbmt.2013.09.011","volume":"19","author":"G Thanarajasingam","year":"2013","unstructured":"Thanarajasingam G, Kim HT, Cutler C, Ho VT, Koreth J, Alyea EP, Antin JH, Soiffer RJ, Armand P (2013) Outcome and prognostic factors for patients who relapse after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 19:1713\u20131718","journal-title":"Biol Blood Marrow Transplant"},{"key":"4089_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/sj.bmt.1700680","volume":"19","author":"K Kishi","year":"1997","unstructured":"Kishi K, Takahashi S, Gondo H, Shiobara S, Kanamaru A, Kato S, Hirabayashi N, Moriyama Y, Harada M, Asano S, Hara H, Shibata A (1997) Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes. Bone Marrow Transplant 19:461\u2013466","journal-title":"Bone Marrow Transplant"},{"key":"4089_CR7","doi-asserted-by":"crossref","unstructured":"Michallet M, Tanguy ML, Socie G, Thiebaut A, Belhabri A, Milpied N, et al (2000) Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM) Br J Haematol 108:400\u2013407","DOI":"10.1046\/j.1365-2141.2000.01851.x"},{"key":"4089_CR8","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1200\/JCO.2001.19.16.3675","volume":"19","author":"A Bosi","year":"2001","unstructured":"Bosi A, Laszlo D, Labopin M, Reffeirs J, Michallet M, Gluckman E, Alessandrino PE, Locatelli F, Vernant JP, Sierra J, Jouet JP, Frassoni F, for the Acute Leukemia Working Party of the European Blood and Marrow Transplant Group (2001) Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European cooperative group for blood and marrow transplantation. J Clin Oncol 19:3675\u20133684","journal-title":"J Clin Oncol"},{"key":"4089_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/sj.bmt.1704645","volume":"34","author":"M Eapen","year":"2004","unstructured":"Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, Tallman MS, Marks DI, Camitta BM, Champlin RE, Ringd\u00e9n O, Bredeson CN, Martino R, Gale RP, Cairo MS, Litzow MR, deLima M (2004) Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplant 34:721\u2013727","journal-title":"Bone Marrow Transplant"},{"key":"4089_CR10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/bmt.2008.255","volume":"42","author":"BE Shaw","year":"2008","unstructured":"Shaw BE, Mufti GJ, Mackinnon S, Cavenagh JD, Pearce RM, Towlson KE, Apperley JF, Chakraverty R, Craddock CF, Kazmi MA, Littlewood TJ, Milligan DW, Pagliuca A, Thomson KJ, Marks DI, Russell NH (2008) Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. Bone Marrow Transplant 42:783\u2013789","journal-title":"Bone Marrow Transplant"},{"key":"4089_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.bbmt.2009.01.009","volume":"15","author":"M Kedmi","year":"2009","unstructured":"Kedmi M, Resnick IB, Dray L, Aker M, Samuel S, Gesundheit B, Slavin S, Or R, Shapira MY (2009) A retrospective review of the outcome after second or subsequent allogeneic transplantation. Biol Blood Marrow Transplant 15:483\u2013489","journal-title":"Biol Blood Marrow Transplant"},{"key":"4089_CR12","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1200\/JCO.2012.44.7961","volume":"31","author":"M Christopeit","year":"2013","unstructured":"Christopeit M, Kuss O, Finke J, Bacher U, Beelen DW, Bornhauser M et al (2013) Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change. J Clin Oncol 31:3259\u20133271","journal-title":"J Clin Oncol"},{"key":"4089_CR13","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/bmt.2015.186","volume":"50","author":"T Ruutu","year":"2015","unstructured":"Ruutu T, de Wreede LC, van Biezen A, Brand R, Mohty M, Dreger P et al (2015) Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT. Bone Marrow Transplant 50:1542\u20131550","journal-title":"Bone Marrow Transplant"},{"key":"4089_CR14","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/bmt.2015.193","volume":"50","author":"G Andreola","year":"2015","unstructured":"Andreola G, Labopin M, Beelen D, Chevallier P, Tabrizi R, Bosi A, Michallet M, Santarone S, Ehninger G, Polge E, Laszlo D, Schmid C, Nagler A, Mohty M (2015) Long-term outcome and prognostic factors of second allogeneic hematopoietic stem cell transplant for acute leukemia in patients with a median follow-up of 10 years. Bone Marrow Transplant 50:1508\u20131512","journal-title":"Bone Marrow Transplant"},{"key":"4089_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bbmt.2015.11.012","volume":"22","author":"G Orti","year":"2016","unstructured":"Orti G, Sanz J, Bermudez A, Caballero D, Martinez C, Sierra J, Cabrera Marin JR, Espigado I, Solano C, Ferr\u00e0 C, Garc\u00eda-Noblejas A, Jimenez S, Sampol A, Ya\u00f1ez L, Garc\u00eda-Guti\u00e9rrez V, Pascual MJ, Jurado M, Moraleda JM, Valcarcel D, Sanz MA, Carreras E, Duarte RF (2016) Outcome of second allogeneic hematopoietic cell transplantation after relapse of myeloid malignancies following allogeneic hematopoietic cell transplantation: a retrospective cohort on behalf of the Grupo Espanol de Trasplante Hematopoyetico. Biol Blood Marrow Transplant 22:584\u2013588","journal-title":"Biol Blood Marrow Transplant"},{"key":"4089_CR16","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jamaoncol.2018.2091","volume":"4","author":"MA Kharfan-Dabaja","year":"2018","unstructured":"Kharfan-Dabaja MA, Labopin M, Polge E, Nishihori T, Bazarbachi A, Finke J, Stadler M, Ehninger G, Lioure B, Schaap N, Afanasyev B, Yeshurun M, Isaksson C, Maertens J, Chalandon Y, Schmid C, Nagler A, Mohty M (2018) Association of second allogeneic hematopoietic cell transplant vs donor lymphocyte infusion with overall survival in patients with acute myeloid leukemia relapse. JAMA Oncol 4:1245\u20131253","journal-title":"JAMA Oncol"},{"key":"4089_CR17","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1007\/s00520-017-3716-6","volume":"25","author":"AMS El-Ghammaz","year":"2017","unstructured":"El-Ghammaz AMS, Ben Matoug R, Elzimaity M, Mostafa N (2017) Nutritional status of allogeneic hematopoietic stem cell transplantation recipients: influencing risk factors and impact on survival. Support Care Cancer 25:3085\u20133093","journal-title":"Support Care Cancer"},{"key":"4089_CR18","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.clnu.2017.03.016","volume":"37","author":"T Brotelle","year":"2018","unstructured":"Brotelle T, Lemal R, Cabrespine A, Combal C, Hermet E, Ravinet A, Bay JO, Bouteloup C (2018) Prevalence of malnutrition in adult patients previously treated with allogeneic hematopoietic stem-cell transplantation. Clin Nutr 37:739\u2013745","journal-title":"Clin Nutr"},{"key":"4089_CR19","doi-asserted-by":"publisher","first-page":"460s","DOI":"10.1093\/ajcn\/66.2.460S","volume":"66","author":"RK Chandra","year":"1997","unstructured":"Chandra RK (1997) Nutrition and the immune system: an introduction. Am J Clin Nutr 66:460s\u2013463s","journal-title":"Am J Clin Nutr"},{"key":"4089_CR20","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.it.2016.04.003","volume":"37","author":"CD Bourke","year":"2016","unstructured":"Bourke CD, Berkley JA, Prendergast AJ (2016) Immune dysfunction as a cause and consequence of malnutrition. Trends Immunol 37:386\u2013398","journal-title":"Trends Immunol"},{"key":"4089_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41409-019-0541-1","volume":"55","author":"S Kaito","year":"2020","unstructured":"Kaito S, Sekiya N, Najima Y, Suzuki T, Wada A, Adachi H, Konuma R, Kishida Y, Nagata A, Konishi T, Yamada Y, Kumagai T, Inamoto K, Yoshifuji K, Akiyama M, Toya T, Igarashi A, Muto H, Doki N, Kobayashi T, Kakihana K, Ohashi K (2020) Nutritional risk index as a risk factor for breakthrough candidemia in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 55:661\u2013664","journal-title":"Bone Marrow Transplant"},{"key":"4089_CR22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/ajcn\/47.2.366","volume":"47","author":"GP Buzby","year":"1988","unstructured":"Buzby GP, Knox LS, Crosby LO, Eisenberg JM, Haakenson CM, McNeal GE et al (1988) Study protocol: a randomized clinical trial of total parenteral nutrition in malnourished surgical patients. Am J Clin Nutr 47:366\u2013381","journal-title":"Am J Clin Nutr"},{"key":"4089_CR23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/ajcn\/82.4.777","volume":"82","author":"O Bouillanne","year":"2005","unstructured":"Bouillanne O, Morineau G, Dupont C, Coulombel I, Vincent JP, Nicolis I, Benazeth S, Cynober L, Aussel C (2005) Geriatric nutritional risk index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr 82:777\u2013783","journal-title":"Am J Clin Nutr"},{"key":"4089_CR24","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00277-018-3273-1","volume":"97","author":"Y Kanemasa","year":"2018","unstructured":"Kanemasa Y, Shimoyama T, Sasaki Y, Hishima T, Omuro Y (2018) Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphoma. Ann Hematol 97:999\u20131007","journal-title":"Ann Hematol"},{"key":"4089_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/ajcn\/87.1.106","volume":"87","author":"K Yamada","year":"2008","unstructured":"Yamada K, Furuya R, Takita T, Maruyama Y, Yamaguchi Y, Ohkawa S, Kumagai H (2008) Simplified nutritional screening tools for patients on maintenance hemodialysis. Am J Clin Nutr 87:106\u2013113","journal-title":"Am J Clin Nutr"},{"key":"4089_CR26","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1253\/circj.CJ-12-1091","volume":"77","author":"Y Kinugasa","year":"2013","unstructured":"Kinugasa Y, Kato M, Sugihara S, Hirai M, Yamada K, Yanagihara K, Yamamoto K (2013) Geriatric nutritional risk index predicts functional dependency and mortality in patients with heart failure with preserved ejection fraction. Circ J 77:705\u2013711","journal-title":"Circ J"},{"key":"4089_CR27","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/jcsm.12025","volume":"6","author":"W Gu","year":"2015","unstructured":"Gu W, Zhang G, Sun L, Ma Q, Cheng Y, Zhang H, Shi G, Zhu Y, Ye D (2015) Nutritional screening is strongly associated with overall survival in patients treated with targeted agents for metastatic renal cell carcinoma. J Cachexia Sarcopenia Muscle 6:222\u2013230","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4089_CR28","doi-asserted-by":"publisher","first-page":"e0155903","DOI":"10.1371\/journal.pone.0155903","volume":"11","author":"Y Bo","year":"2016","unstructured":"Bo Y, Wang K, Liu Y, You J, Cui H, Zhu Y, Lu Q, Yuan L (2016) The geriatric nutritional risk index predicts survival in elderly esophageal squamous cell carcinoma patients with radiotherapy. PLoS One 11:e0155903","journal-title":"PLoS One"},{"key":"4089_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000447147","volume":"10","author":"H Miyake","year":"2017","unstructured":"Miyake H, Tei H, Fujisawa M (2017) Geriatric nutrition risk index is an important predictor of cancer-specific survival, but not recurrence-free survival, in patients undergoing surgical resection for non-metastatic renal cell carcinoma. Curr Urol 10:26\u201331","journal-title":"Curr Urol"},{"key":"4089_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/icvts\/ivx337","volume":"26","author":"F Shoji","year":"2018","unstructured":"Shoji F, Miura N, Matsubara T, Akamine T, Kozuma Y, Haratake N, Takamori S, Katsura M, Takada K, Toyokawa G, Takenaka T, Yamazaki K, Okamoto T, Takeo S, Maehara Y (2018) Prognostic significance of immune-nutritional parameters for surgically resected elderly lung cancer patients: a multicentre retrospective study. Interact Cardiovasc Thorac Surg 26:389\u2013394","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"4089_CR31","doi-asserted-by":"publisher","first-page":"12561","DOI":"10.1038\/s41598-018-30906-8","volume":"8","author":"L Li","year":"2018","unstructured":"Li L, Wang H, Yang J, Jiang L, Yang J, Wu H, Wen T, Yan L (2018) Geriatric nutritional risk index predicts prognosis after hepatectomy in elderly patients with hepatitis B virus-related hepatocellular carcinoma. Sci Rep 8:12561","journal-title":"Sci Rep"},{"key":"4089_CR32","doi-asserted-by":"publisher","first-page":"e000730","DOI":"10.1136\/openhrt-2017-000730","volume":"5","author":"A Yoshihisa","year":"2018","unstructured":"Yoshihisa A, Kanno Y, Watanabe S, Yokokawa T, Abe S, Miyata M, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Suzuki H, Ishida T, Takeishi Y (2018) Impact of nutritional indices on mortality in patients with heart failure. Open Heart 5:e000730","journal-title":"Open Heart"},{"key":"4089_CR33","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3390\/nu10060765","volume":"10","author":"H Sasaki","year":"2018","unstructured":"Sasaki H, Nagano S, Komiya S, Taniguchi N, Setoguchi T (2018) Validation of different nutritional assessment tools in predicting prognosis of patients with soft tissue spindle-cell sarcomas. Nutrients 10:765","journal-title":"Nutrients"},{"key":"4089_CR34","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1007\/s00277-019-03668-0","volume":"98","author":"T Konishi","year":"2019","unstructured":"Konishi T, Doki N, Kishida Y, Nagata A, Yamada Y, Kaito S, Kurosawa S, Yoshifuji K, Shirane S, Uchida T, Inamoto K, Toya T, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K (2019) Geriatric nutritional risk index (GNRI) just before allogeneic hematopoietic stem cell transplantation predicts transplant outcomes in patients older than 50 years with acute myeloid leukemia in complete remission. Ann Hematol 98:1799\u20131801","journal-title":"Ann Hematol"},{"key":"4089_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/ejh.12999","volume":"100","author":"M Okada","year":"2018","unstructured":"Okada M, Tasaka T, Ikegame K, Aotsuka N, Kobayashi T, Najima Y, Matsuhashi Y, Wada H, Tokunaga H, Masuda S, Utsu Y, Yoshihara S, Kaida K, Daimon T, Ogawa H (2018) A prospective multicenter phase II study of intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning. Eur J Haematol 100:335\u2013343","journal-title":"Eur J Haematol"},{"key":"4089_CR36","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106:2912\u20132919","journal-title":"Blood"},{"key":"4089_CR37","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/bmt.2014.293","volume":"50","author":"H Nakasone","year":"2015","unstructured":"Nakasone H, Fukuda T, Kanda J, Mori T, Yano S, Kobayashi T et al (2015) Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation. Bone Marrow Transplant 50:559\u2013565","journal-title":"Bone Marrow Transplant"},{"key":"4089_CR38","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED (1995) 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 15:825\u2013828","journal-title":"Bone Marrow Transplant"},{"key":"4089_CR39","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69:204\u2013217","journal-title":"Am J Med"},{"key":"4089_CR40","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.bbmt.2015.04.012","volume":"21","author":"K Ikegame","year":"2015","unstructured":"Ikegame K, Yoshida T, Yoshihara S, Daimon T, Shimizu H, Maeda Y, Ueda Y, Kaida K, Ishii S, Taniguchi K, Okada M, Tamaki H, Okumura H, Kaya H, Kurokawa T, Kodera Y, Taniguchi S, Kanda Y, Ogawa H (2015) Unmanipulated haploidentical reduced-intensity stem cell transplantation using fludarabine, busulfan, low-dose antithymocyte globulin, and steroids for patients in non-complete remission or at high risk of relapse: a prospective multicenter phase I\/II study in Japan. Biol Blood Marrow Transplant 21:1495\u20131505","journal-title":"Biol Blood Marrow Transplant"},{"key":"4089_CR41","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","volume":"15","author":"S Giralt","year":"2009","unstructured":"Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, Sandmaier B (2009) Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 15:367\u2013369","journal-title":"Biol Blood Marrow Transplant"},{"key":"4089_CR42","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48:452\u2013458","journal-title":"Bone Marrow Transplant"},{"key":"4089_CR43","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.3324\/haematol.2016.145847","volume":"2101","author":"AS Artz","year":"2016","unstructured":"Artz AS, Logan B, Zhu X, Akpek G, Bufarull RM, Gupta V et al (2016) The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes. Haematologica 2101:1426\u20131433","journal-title":"Haematologica"},{"key":"4089_CR44","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/bmt.2014.178","volume":"49","author":"S Fuji","year":"2014","unstructured":"Fuji S, Takano K, Mori T, Eto T, Taniguchi S, Ohashi K, Sakamaki H, Morishima Y, Kato K, Miyamura K, Suzuki R, Fukuda T (2014) Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT. Bone Marrow Transplant 49:1505\u20131512","journal-title":"Bone Marrow Transplant"},{"key":"4089_CR45","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.bbmt.2018.10.006","volume":"25","author":"K Doney","year":"2019","unstructured":"Doney K, McMillen K, Buono L, Deeg HJ, Gooley T (2019) Impact of body mass index on outcomes of hematopoietic stem cell transplantation in adults. Biol Blood Marrow Transplant 25:613\u2013620","journal-title":"Biol Blood Marrow Transplant"},{"key":"4089_CR46","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.clnu.2013.07.012","volume":"33","author":"R Guieze","year":"2014","unstructured":"Guieze R, Lemal R, Cabrespine A, Hermet E, Tournilhac O, Combal C et al (2014) Enteral versus parenteral nutritional support in allogeneic haematopoietic stem-cell transplantation. Clin Nutr 33:533\u2013538","journal-title":"Clin Nutr"},{"key":"4089_CR47","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/TP.0b013e3182558f60","volume":"94","author":"D Seguy","year":"2012","unstructured":"Seguy D, Duhamel A, Rejeb MB, Gomez E, Buhl ND, Bruno B, Cortot A, Yakoub-Agha I (2012) Better outcome of patients undergoing enteral tube feeding after myeloablative conditioning for allogeneic stem cell transplantation. Transplantation 94:287\u2013294","journal-title":"Transplantation"},{"key":"4089_CR48","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/bmt.2016.310","volume":"52","author":"A Baumgartner","year":"2017","unstructured":"Baumgartner A, Bargetzi A, Zueger N, Bargetzi M, Medinger M, Bounoure L, Gomes F, Stanga Z, Mueller B, Schuetz P (2017) Revisiting nutritional support for allogeneic hematologic stem cell transplantation\u2014a systematic review. Bone Marrow Transplant 52:506\u2013513","journal-title":"Bone Marrow Transplant"},{"key":"4089_CR49","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/bmt.2014.83","volume":"49","author":"J Tischer","year":"2014","unstructured":"Tischer J, Engel N, Fritsch S, Prevalsek D, Hubmann M, Schulz C, Zoellner AK, B\u00fccklein V, Lippl S, Reibke R, Rieger CT, Ledderose G, Stemmler HJ, Hiddemann W, Schmid C, Hausmann A (2014) Second haematopoietic SCT using HLA-haploidentical donors in patients with relapse of acute leukaemia after a first allogeneic transplantation. Bone Marrow Transplant 49:895\u2013901","journal-title":"Bone Marrow Transplant"},{"key":"4089_CR50","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/bmt.2015.67","volume":"50","author":"SP Yeh","year":"2015","unstructured":"Yeh SP, Lin CC, Lin CH, Lo WC, Chen TT, Lo WJ, Lin CL, Chiu CF (2015) Second haploidentical peripheral blood stem cell transplantation for treatment of acute leukemia with relapse after first allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 50:1001\u20131003","journal-title":"Bone Marrow Transplant"},{"key":"4089_CR51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/10428194.2015.1045900","volume":"57","author":"T Konuma","year":"2016","unstructured":"Konuma T, Kato S, Ooi J, Ebihara Y, Mochizuki S, Ishii H, Takei T, Oiwa-Monna M, Tojo A, Takahashi S (2016) Second allogeneic transplantation using unrelated cord blood for relapsed hematological malignancies after allogeneic transplantation. Leuk Lymphoma 57:103\u2013109","journal-title":"Leuk Lymphoma"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04089-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-020-04089-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04089-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T23:19:38Z","timestamp":1623280778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-020-04089-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,10]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["4089"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04089-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,10]]},"assertion":[{"value":"26 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and approved by the ethics committee of Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital (permission number 2178).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}